-
1
-
-
0036181394
-
Inflammation in acute coronary syndromes
-
MULVIHILL, N.T., J.B. FOLEY. 2002. Inflammation in acute coronary syndromes. Heart 87: 201-204.
-
(2002)
Heart
, vol.87
, pp. 201-204
-
-
MULVIHILL, N.T.1
FOLEY, J.B.2
-
2
-
-
0033660004
-
-
FROHLICH, M., A. IMHOF, G. BERG, et al. 2000. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 1835-1839.
-
FROHLICH, M., A. IMHOF, G. BERG, et al. 2000. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 1835-1839.
-
-
-
-
3
-
-
0030956673
-
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
-
RIDKER, P.M., M. CUSHMAN, M.J. STAMPFER, et al. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 973-979.
-
(1997)
N. Engl. J. Med
, pp. 973-979
-
-
RIDKER, P.M.1
CUSHMAN, M.2
STAMPFER, M.J.3
-
4
-
-
0029810933
-
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial
-
KULLER, L.H., R.P. TRACY, J. SHATEN, et al. 1996. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 144: 537-547.
-
(1996)
Am. J. Epidemiol
, vol.144
, pp. 537-547
-
-
KULLER, L.H.1
TRACY, R.P.2
SHATEN, J.3
-
5
-
-
0028816015
-
Is atherosclerosis an immunologically mediated disease?
-
WICK, G., G. SCHETT, A. AMBERGER, et al. 1995. Is atherosclerosis an immunologically mediated disease? Immunol. Today 16: 27-33.
-
(1995)
Immunol. Today
, vol.16
, pp. 27-33
-
-
WICK, G.1
SCHETT, G.2
AMBERGER, A.3
-
6
-
-
0034090507
-
Autoimmunity in atherosclerosis: Lessons from experimental models
-
GEORGE, J., A. AFEK, B. GILBURD, et al. 2000. Autoimmunity in atherosclerosis: lessons from experimental models. Lupus 9: 223-227.
-
(2000)
Lupus
, vol.9
, pp. 223-227
-
-
GEORGE, J.1
AFEK, A.2
GILBURD, B.3
-
7
-
-
0002528456
-
Vascularwall function as a risk marker for cardiovascular disease
-
COHN, J.N. 1999. Vascularwall function as a risk marker for cardiovascular disease. J. Hypertens. 17(Suppl 5): S41-S44.
-
(1999)
J. Hypertens
, vol.17
, Issue.SUPPL. 5
-
-
COHN, J.N.1
-
8
-
-
0032843358
-
Pathophysiologic and prognostic implications of measuring arterial compliance in hypertensive disease
-
COHN, J.N. 1999. Pathophysiologic and prognostic implications of measuring arterial compliance in hypertensive disease. Prog. Cardiovasc. Dis. 41: 441-450.
-
(1999)
Prog. Cardiovasc. Dis
, vol.41
, pp. 441-450
-
-
COHN, J.N.1
-
9
-
-
0031052874
-
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosis: Comparison with the Framingham study
-
MANZI, S., E.N. MEILAHN, J.E. RAIRIE, et al. 1997. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosis: comparison with the Framingham study. Am. J. Epidemiol. 145: 408-415.
-
(1997)
Am. J. Epidemiol
, vol.145
, pp. 408-415
-
-
MANZI, S.1
MEILAHN, E.N.2
RAIRIE, J.E.3
-
10
-
-
0026459695
-
Risk factors for coronary artery disease in patients with systemic lupus erythematosis
-
PETRI, M., S. PEREZ-GUTTHANN, D. SPENCE, et al. 1992. Risk factors for coronary artery disease in patients with systemic lupus erythematosis. Am. J. Med. 93: 513-519.
-
(1992)
Am. J. Med
, vol.93
, pp. 513-519
-
-
PETRI, M.1
PEREZ-GUTTHANN, S.2
SPENCE, D.3
-
11
-
-
0033004426
-
Premature morbidity from cardiovascular and cerebrovascular disease in women with systemic lupus erythematosis
-
WARD, M.M. 1999. Premature morbidity from cardiovascular and cerebrovascular disease in women with systemic lupus erythematosis. Arthritis Rheum. 42: 338-346.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 338-346
-
-
WARD, M.M.1
-
12
-
-
0035050697
-
Vascular stiffness in women with systemic lupus erythematosis
-
SELZER, F., K. SUTTON-TYRRELL, S. FITZGERALD, et al. 2001. Vascular stiffness in women with systemic lupus erythematosis. Hypertension 37: 1075-1082.
-
(2001)
Hypertension
, vol.37
, pp. 1075-1082
-
-
SELZER, F.1
SUTTON-TYRRELL, K.2
FITZGERALD, S.3
-
13
-
-
0035673761
-
Atherosclerosis & connective tissue disease
-
MEYER O. 2001. Atherosclerosis & connective tissue disease. Joint Bone Spine 68: 564-575.
-
(2001)
Joint Bone Spine
, vol.68
, pp. 564-575
-
-
MEYER, O.1
-
14
-
-
0034761724
-
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosis
-
ESDAILE, J.M., M. ABRAHAMOWICZ, T. GRODZICKY, et al. 2001. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosis. Arthritis Rheum. 44: 2331-2337.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2331-2337
-
-
ESDAILE, J.M.1
ABRAHAMOWICZ, M.2
GRODZICKY, T.3
-
15
-
-
0142156507
-
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosis
-
DORIA, A., Y. SHOENFELD, R. WU, et al. 2003. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosis. Ann. Rheum. Dis. 62: 1071-1077.
-
(2003)
Ann. Rheum. Dis
, vol.62
, pp. 1071-1077
-
-
DORIA, A.1
SHOENFELD, Y.2
WU, R.3
-
16
-
-
0346030568
-
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosis
-
ROMAN, M.J., B.A. SHANKER, D.A. LOCKSHIN, et al. 2003. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosis. N. Engl. J. Med. 349: 2399-2406.
-
(2003)
N. Engl. J. Med
, vol.349
, pp. 2399-2406
-
-
ROMAN, M.J.1
SHANKER, B.A.2
LOCKSHIN, D.A.3
-
17
-
-
13244268504
-
Determination of arterial compliance using blood pressure waveform analysis, with the CR-2000 system - reliability, repeatability and establishment of normal values for healthy European population. The Seven European Sites Study (SESS)
-
ZIMLICHMAN, R., M. BOAZ, M. SHARGORODSKY, et al. 2005. Determination of arterial compliance using blood pressure waveform analysis, with the CR-2000 system - reliability, repeatability and establishment of normal values for healthy European population. The Seven European Sites Study (SESS). Am. J. Hypertension. 1:8 65-71.
-
(2005)
Am. J. Hypertension
, vol.1
, Issue.8
, pp. 65-71
-
-
ZIMLICHMAN, R.1
BOAZ, M.2
SHARGORODSKY, M.3
-
18
-
-
0029764927
-
Thrombosis and systemic lupus erythematosis: The Hopkins Lupus Cohort perspective
-
PETRI, M. 1996. Thrombosis and systemic lupus erythematosis: the Hopkins Lupus Cohort perspective. Scand. J. Rheumatol. 25: 191-193.
-
(1996)
Scand. J. Rheumatol
, vol.25
, pp. 191-193
-
-
PETRI, M.1
-
19
-
-
0016644434
-
Inhibitors of platelet function in the prevention of arterial thrombosis
-
HARKER, L.A. 1975. Inhibitors of platelet function in the prevention of arterial thrombosis. Ser. Haematol. 8: 105-124.
-
(1975)
Ser. Haematol
, vol.8
, pp. 105-124
-
-
HARKER, L.A.1
-
20
-
-
0029990745
-
Hydroxychloroquine use in the Baltimore Lupus Cohort: Effects on lipids, glucose and thrombosis
-
PETRI, M. 1996. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 5(Suppl 1): S16-S22.
-
(1996)
Lupus
, vol.5
, Issue.SUPPL. 1
-
-
PETRI, M.1
-
21
-
-
0032900519
-
The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs
-
RAHMAN, P., D.D. GLADMAN, M.B. UROWITZ, et al. 1999. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J. Rheumatol. 26: 325-330
-
(1999)
J. Rheumatol
, vol.26
, pp. 325-330
-
-
RAHMAN, P.1
GLADMAN, D.D.2
UROWITZ, M.B.3
-
22
-
-
0033601472
-
Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats
-
EMAMI, J., F.M. PASUTTO, J.R. MERCER, et al. 1999. Inhibition of insulin metabolism by hydroxychloroquine and its enantiomers in cytosolic fraction of liver homogenates from healthy and diabetic rats. Life Sci. 64: 325-335.
-
(1999)
Life Sci
, vol.64
, pp. 325-335
-
-
EMAMI, J.1
PASUTTO, F.M.2
MERCER, J.R.3
-
23
-
-
0036175209
-
The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas-a randomized trial
-
GERSTEIN, H.C., K.E. THORPE, D.W. TAYLOR, et al. 2002. The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas-a randomized trial. Diabetes Res. Clin. Pract. 55: 209-219.
-
(2002)
Diabetes Res. Clin. Pract
, vol.55
, pp. 209-219
-
-
GERSTEIN, H.C.1
THORPE, K.E.2
TAYLOR, D.W.3
|